An international team of researchers, including scientists from the Institute for Systems Biology, has conducted one of the most comprehensive molecular studies of human diversity to date. Published in Cell, the work reveals how ethnicity and geography influence metabolism, immunity, the microbiome, and biological aging — insights that could help advance precision medicine for diverse populations.
New research from ISB’s Gibbons Lab shows that computer models of gut metabolism can predict whether probiotics will successfully establish in an individual’s microbiome and how dietary prebiotics shape health-related molecules in the gut. The findings point toward a future of more personalized, predictable microbiome-based interventions.
Six leading experts from across the field presented new insights to more than 1,000 registrants worldwide, with over 400 participants joining live.
There has been an explosion of research into the two-way communication between the gut microbiota and the brain. This year, ISB hosted a virtual microbiome series dedicated to exploring the gut-brain axis.
The 2023 ISB Virtual Microbiome Series consisted of a two-day virtual course and one-day symposium on how the ecology of our guts protects us from pathogens.
The 2022 ISB Virtual Microbiome Series consisted of a two-day virtual course and one-day symposium on global perspectives in microbiome research.
The 2021 ISB Virtual Microbiome Series highlighted recent advances toward understanding general patterns of commensal population genomic variation within the human gut, how fine-scale commensal genomic variation is influenced by host phenotypic variation, and whether or not commensal genomic variation has an impact on human health and disease.
The inaugural ISB Virtual Microbiome Series highlighted recent in silico, in vitro, and in vivo advances toward engineering the gut microbiome to resolve complex diseases.